oleic acid has been researched along with itraconazole in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Haber, T; Pardeike, J; Plank, H; Wagner, J; Weber, S; Zarfl, HP; Zimmer, A | 1 |
| Chi, SC; Choi, NY; Ha, JM; Kim, JY; Oh, TO; Park, CW; Park, ES; Rhee, YS | 1 |
| Kim, D; Lee, BJ; Meghani, NM; Park, C; Park, JB; Tran, PHL; Tran, TTD | 1 |
| Cai, L; Chen, J; Ji, M; Ruan, G; Song, Y; Wang, J; Zhou, L; Zhu, P | 1 |
5 other study(ies) available for oleic acid and itraconazole
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application.
Topics: Administration, Inhalation; Antifungal Agents; Diglycerides; Drug Carriers; Drug Stability; Drug Storage; Excipients; Itraconazole; Lipids; Lung; Nanoparticles; Nebulizers and Vaporizers; Oleic Acid; Particle Size; Solubility; Sterilization; Transition Temperature | 2011 |
Preparation and valuation of a topical solution containing eutectic mixture of itraconazole and phenol.
Topics: Administration, Cutaneous; Animals; Antifungal Agents; Benzyl Alcohol; Excipients; Hypromellose Derivatives; Itraconazole; Male; Methylcellulose; Mice; Mice, Hairless; Mice, Inbred ICR; Oleic Acid; Permeability; Phenol; Rabbits; Rats; Rats, Sprague-Dawley; Skin Absorption | 2012 |
Utilization of a fattigation platform gelatin-oleic acid sodium salt conjugate as a novel solubilizing adjuvant for poorly water-soluble drugs via self-assembly and nanonization.
Topics: Adjuvants, Pharmaceutic; Aprepitant; Cilostazol; Drug Liberation; Gelatin; Intestinal Secretions; Itraconazole; Nanoparticles; Oleic Acid; Solubility; Telmisartan; Ticagrelor; Water | 2020 |
Encapsulating insoluble antifungal drugs into oleic acid-modified silica mesocomposites with enhanced fungicidal activity.
Topics: Antifungal Agents; Aspergillus fumigatus; Candida albicans; Capsules; Cetrimonium; Itraconazole; Microbial Sensitivity Tests; Molecular Structure; Oleic Acid; Particle Size; Silicon Dioxide; Solubility; Surface Properties | 2020 |